EUVIMEDEuropean Health Evidence
Uhr Sources10/10 Journal Tree
Easy Demo

European Health Evidence

The European alternative to PubMed

EUVIMED is the European alternative to PubMed: a central, multilingual research platform for medicine, nursing, life sciences and healthcare. It brings together international and European literature sources, study registries, open-access full texts, citations and retraction notices in one search. Unlike pure bibliographic databases, EUVIMED supports the entire research process – from discovery and appraisal with LIVIA and CLARA to traceable evidence synthesis. European in focus, transparent, interoperable and designed for science and healthcare.

EuropeanMultilingualInteroperableTraceable

EUVIMED BETA

EUVIMED is currently in beta

EUVIMED is under continuous development. Features, data coverage and presentation may change or be temporarily incomplete.

Results are beta

Search results, classifications, summaries and AI-assisted assessments may be incomplete, delayed or incorrect.

Check original sources

Do not use EUVIMED results without verification for diagnosis, treatment or other clinical decisions. Always consult the original source and applicable guidelines.

Errors and feedback help us improve EUVIMED: info@euvimed.com

Lokaler Crossref-Datenbestand · journal-article

Cryptococcus-targeted culture in dogs reveals nasal carriage of Naganishia albida and diverse opportunistic yeasts with potential clinical relevance

Enes Said Gündüz, Kadir Semih Gümüşsoy, Ayşe Nedret Koç

American Journal of Veterinary Research · 2026

Vollständiger Abstract

Worum geht es in dieser Arbeit?

Abstract Objective To investigate the nasal carriage of Cryptococcus -related and other opportunistic yeasts in dogs, molecularly characterize the recovered isolates, and evaluate the epidemiological characteristics of Naganishia albida carriage. Methods Nasal swab samples were collected from July through December 2023 from 100 dogs receiving boarding or hospitalization services at private veterinary clinics and animal hospitals in 4 provinces of Türkiye. Yeast isolates were identified using phenotypic methods, internal transcribed spacer 2 sequencing, and matrix-assisted laser desorption ionization–time-of-flight mass spectrometry. The 1-year clinical history of dogs carrying N albida was retrospectively reviewed. Results A total of 79 isolates representing 31 yeast species were identified from 59 dogs. Cryptococcus neoformans / gattii species complex organisms were not isolated from any dog. Naganishia albida and Papiliotrema laurentii were isolated from 12% and 1% of dogs, respectively. Naganishia albida carriage was detected in both clinically healthy and clinically affected dogs, with higher frequencies observed among dogs presenting with respiratory, dermatological, or systemic clinical findings. However, no significant associations were identified between N albida carriage and the evaluated epidemiological variables. Conclusions Dogs may harbor diverse opportunistic yeasts, including Cryptococcus -related yeasts, within the nasal cavity. Clinical Relevance Opportunistic yeasts can colonize the nasal cavities of both clinically healthy and clinically affected dogs. These findings provide baseline epidemiological data for interpreting fungal culture results and contribute to a better understanding of opportunistic fungal carriage in companion animals.

Bibliografischer Nachweis

Publikationsdaten

Autor:innen
Enes Said Gündüz, Kadir Semih Gümüşsoy, Ayşe Nedret Koç
Quelle
American Journal of Veterinary Research
Publikation
2026-01-01
Band / Ausgabe
Nicht angegeben
Seiten
Nicht angegeben
ISSN / ISBN
0002-9645, 1943-5681
Zitationen
0 laut Crossref
Referenzen
0 hinterlegt

Zitieren

Zitierfähiger Nachweis

Enes Said Gündüz, Kadir Semih Gümüşsoy, Ayşe Nedret Koç (2026). Cryptococcus-targeted culture in dogs reveals nasal carriage of Naganishia albida and diverse opportunistic yeasts with potential clinical relevance. American Journal of Veterinary Research. https://doi.org/10.2460/ajvr.26.06.0278
RIS BibTeX CSL-JSON

Kontext

Themen, Förderung und Nutzung

Lizenzhinweise: Lizenz 1